Cargando…

Safety of TeaCrine®, a non-habituating, naturally-occurring purine alkaloid over eight weeks of continuous use

BACKGROUND: Theacrine (1,3,7,9-tetramethyluric acid) is a purine alkaloid found in certain coffee (Coffea) species, fruits (Cupuacu [Theobroma grandiflorum]), and tea (Camellia assamica, var. kucha) that has anti-inflammatory, analgesic, and neuro-locomotor properties. Recent preliminary research ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Taylor, Lem, Mumford, Petey, Roberts, Mike, Hayward, Sara, Mullins, Jacy, Urbina, Stacie, Wilborn, Colin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4711067/
https://www.ncbi.nlm.nih.gov/pubmed/26766930
http://dx.doi.org/10.1186/s12970-016-0113-3
_version_ 1782409912342544384
author Taylor, Lem
Mumford, Petey
Roberts, Mike
Hayward, Sara
Mullins, Jacy
Urbina, Stacie
Wilborn, Colin
author_facet Taylor, Lem
Mumford, Petey
Roberts, Mike
Hayward, Sara
Mullins, Jacy
Urbina, Stacie
Wilborn, Colin
author_sort Taylor, Lem
collection PubMed
description BACKGROUND: Theacrine (1,3,7,9-tetramethyluric acid) is a purine alkaloid found in certain coffee (Coffea) species, fruits (Cupuacu [Theobroma grandiflorum]), and tea (Camellia assamica, var. kucha) that has anti-inflammatory, analgesic, and neuro-locomotor properties. Recent preliminary research has also reported increased feelings of energy, reduced fatigue, and strong effects on improving focus, concentration, and motivation to exercise. The purpose of this study was to examine the safety and non-habituating effects of TeaCrine®, a nature-identical, chemically equivalent bioactive version of theacrine. METHODS: Sixty healthy men (mean ± SD age, height, weight: 22.9 ± 4.7 years, 183.5 ± 9.2 cm, 86.5 ± 13.7 kg) and women (22.3 ± 4.5 years, 165.2 ± 12.3 cm, 69.0 ± 17.4 kg) were placed into one of three groups: placebo (PLA, n = 20), 200 mg TeaCrine® (LD, n = 19) or 300 mg Teacrine® (HD, n = 21) and ingested their respective supplement once daily for 8 weeks. Primary outcomes were fasting clinical safety markers (heart rate, blood pressure, lipid profiles, hematologic blood counts, biomarkers of liver/kidney/immune function) and energy, focus, concentration, anxiety, motivation to exercise, and POMS measured prior to daily dosing to ascertain potential tachyphylactic responses and habituation effects. Data were analyzed via two-way (group × time) ANOVAs and statistical significance was accepted at p < 0.05. RESULTS: All values for clinical safety markers fell within normal limits and no group × time interactions were noted. No evidence of habituation was noted as baseline values for energy, focus, concentration, anxiety, motivation to exercise, and POMS remained stable in all groups across the 8-week study protocol. CONCLUSIONS: These findings support the clinical safety and non-habituating neuro-energetic effects of TeaCrine® supplementation over 8 weeks of daily use (up to 300 mg/day). Moreover, there was no evidence of a tachyphylactic response that is typical of neuroactive agents such as caffeine and other stimulants.
format Online
Article
Text
id pubmed-4711067
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-47110672016-01-14 Safety of TeaCrine®, a non-habituating, naturally-occurring purine alkaloid over eight weeks of continuous use Taylor, Lem Mumford, Petey Roberts, Mike Hayward, Sara Mullins, Jacy Urbina, Stacie Wilborn, Colin J Int Soc Sports Nutr Research Article BACKGROUND: Theacrine (1,3,7,9-tetramethyluric acid) is a purine alkaloid found in certain coffee (Coffea) species, fruits (Cupuacu [Theobroma grandiflorum]), and tea (Camellia assamica, var. kucha) that has anti-inflammatory, analgesic, and neuro-locomotor properties. Recent preliminary research has also reported increased feelings of energy, reduced fatigue, and strong effects on improving focus, concentration, and motivation to exercise. The purpose of this study was to examine the safety and non-habituating effects of TeaCrine®, a nature-identical, chemically equivalent bioactive version of theacrine. METHODS: Sixty healthy men (mean ± SD age, height, weight: 22.9 ± 4.7 years, 183.5 ± 9.2 cm, 86.5 ± 13.7 kg) and women (22.3 ± 4.5 years, 165.2 ± 12.3 cm, 69.0 ± 17.4 kg) were placed into one of three groups: placebo (PLA, n = 20), 200 mg TeaCrine® (LD, n = 19) or 300 mg Teacrine® (HD, n = 21) and ingested their respective supplement once daily for 8 weeks. Primary outcomes were fasting clinical safety markers (heart rate, blood pressure, lipid profiles, hematologic blood counts, biomarkers of liver/kidney/immune function) and energy, focus, concentration, anxiety, motivation to exercise, and POMS measured prior to daily dosing to ascertain potential tachyphylactic responses and habituation effects. Data were analyzed via two-way (group × time) ANOVAs and statistical significance was accepted at p < 0.05. RESULTS: All values for clinical safety markers fell within normal limits and no group × time interactions were noted. No evidence of habituation was noted as baseline values for energy, focus, concentration, anxiety, motivation to exercise, and POMS remained stable in all groups across the 8-week study protocol. CONCLUSIONS: These findings support the clinical safety and non-habituating neuro-energetic effects of TeaCrine® supplementation over 8 weeks of daily use (up to 300 mg/day). Moreover, there was no evidence of a tachyphylactic response that is typical of neuroactive agents such as caffeine and other stimulants. BioMed Central 2016-01-13 /pmc/articles/PMC4711067/ /pubmed/26766930 http://dx.doi.org/10.1186/s12970-016-0113-3 Text en © Taylor et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Taylor, Lem
Mumford, Petey
Roberts, Mike
Hayward, Sara
Mullins, Jacy
Urbina, Stacie
Wilborn, Colin
Safety of TeaCrine®, a non-habituating, naturally-occurring purine alkaloid over eight weeks of continuous use
title Safety of TeaCrine®, a non-habituating, naturally-occurring purine alkaloid over eight weeks of continuous use
title_full Safety of TeaCrine®, a non-habituating, naturally-occurring purine alkaloid over eight weeks of continuous use
title_fullStr Safety of TeaCrine®, a non-habituating, naturally-occurring purine alkaloid over eight weeks of continuous use
title_full_unstemmed Safety of TeaCrine®, a non-habituating, naturally-occurring purine alkaloid over eight weeks of continuous use
title_short Safety of TeaCrine®, a non-habituating, naturally-occurring purine alkaloid over eight weeks of continuous use
title_sort safety of teacrine®, a non-habituating, naturally-occurring purine alkaloid over eight weeks of continuous use
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4711067/
https://www.ncbi.nlm.nih.gov/pubmed/26766930
http://dx.doi.org/10.1186/s12970-016-0113-3
work_keys_str_mv AT taylorlem safetyofteacrineanonhabituatingnaturallyoccurringpurinealkaloidovereightweeksofcontinuoususe
AT mumfordpetey safetyofteacrineanonhabituatingnaturallyoccurringpurinealkaloidovereightweeksofcontinuoususe
AT robertsmike safetyofteacrineanonhabituatingnaturallyoccurringpurinealkaloidovereightweeksofcontinuoususe
AT haywardsara safetyofteacrineanonhabituatingnaturallyoccurringpurinealkaloidovereightweeksofcontinuoususe
AT mullinsjacy safetyofteacrineanonhabituatingnaturallyoccurringpurinealkaloidovereightweeksofcontinuoususe
AT urbinastacie safetyofteacrineanonhabituatingnaturallyoccurringpurinealkaloidovereightweeksofcontinuoususe
AT wilborncolin safetyofteacrineanonhabituatingnaturallyoccurringpurinealkaloidovereightweeksofcontinuoususe